Identification of novel target genes involved in Indian Fanconi anemia patients using microarray

Gene

Volumn 531, Issue 2, 2013, Pages 444-450

  Shyamsunder, Pavithra ^a   Ganesh, Kripa S ^a   Vidyasekar, Prasanna ^a   Mohan, Sheila ^b   Verma, Rama Shanker ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b Durgabai Deshmukh General Hospital and Research Center   (India)

Author keywords

Fanconi anemia; Hematological abnormalities; Impaired immunity; Microarray; Oxygen sensitivity

Indexed keywords

ATXN 3 PROTEIN; DNA; MEMBRANE PROTEIN; RETINOBLASTOMA BINDING PROTEIN 1; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL CYCLE; CHROMOSOME STRUCTURE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; DOWN REGULATION; FANCONI ANEMIA; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; INDIAN; INTRACELLULAR TRANSPORT; MEMBRANE STRUCTURE; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSCRIPTION REGULATION;

ACUTE MYELOID LEUKEMIA; AML; ARID4A; AT RICH INTERACTIVE DOMAIN 4A (RBP1-LIKE); ATAXIN-3; ATXN3; BM; BONE MARROW; CHRONIC MYELOMONOCYTIC LEUKEMIA; CMML; DEB; DIEPOXYBUTANE; ETS1; FA; FANCONI ANEMIA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMATOLOGICAL ABNORMALITIES; HNSCC; ICL; IMPAIRED IMMUNITY; INTERSTRAND CROSSLINKS; MICROARRAY; MITOMYCIN C; MMC; NATURAL KILLER; NK; OXYGEN SENSITIVITY; REACTIVE OXYGEN SPECIES; ROS; SOD; SUPEROXIDE DISMUTASE; V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 1;

CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE ONTOLOGY; HUMANS; INDIA; MALE; MICROARRAY ANALYSIS; VALIDATION STUDIES AS TOPIC;

EID: 84885419702     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.08.082     Document Type: Article

References (43)

1. Afonso V., Champy R., Mitrovic D., Collin P., Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint, Bone, Spine 2007, 74:324-329.
2. Anderson M.K., Hernandez-Hoyos G., Diamond R.A., Rothenberg E.V. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 1999, 126:3131-3148.
3. Araujo J., et al. FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. Hum. Mol. Genet. 2011, 20:2928-2941.
4. Barton K., et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 1998, 9:555-563.
5. Bassuk A.G., Leiden J.M. The role of Ets transcription factors in the development and function of the mammalian immune system. Adv. Immunol. 1997, 64:65-104.
6. Bories J.C., et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 1995, 377:635-638.
7. Butturini A., Gale R.P., Verlander P.C., Adler-Brecher B., Gillio A.P., Auerbach A.D. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994, 84:1650-1655.
8. Castello G., Gallo C., Napolitano M., Ascierto P.A. Immunological phenotype analysis of patients with Fanconi's anaemia and their family members. Acta Haematol. 1998, 100:39-43.
9. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 2001, 7:814-820.
10. D'Andrea A., Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood 1997, 90:1725-1736.
11. Dokal I. Heightened DNA damage response impairs hematopoiesis in Fanconi anemia. Haematologica 2012, 97:1117.
12. Du W., Adam Z., Rani R., Zhang X., Pang Q. Oxidative stress in Fanconi anemia hematopoiesis and disease progression. Antioxid. Redox Signal. 2008, 10:1909-1921.
13. Dufour C., et al. TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. Blood 2003, 102:2053-2059.
14. Eyquem S., et al. The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factor. Eur. J. Immunol. 2004, 34:3187-3196.
15. Froom P., Aghai E., Dobinsky J.B., Quitt M., Lahat N. Reduced natural killer activity in patients with Fanconi's anemia and in family members. Leuk. Res. 1987, 11:197-199.
16. Futaki M., et al. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 2002, 23:67-72.
17. Golubnitschaja O., Moenkemann H., Trog D.B., Blom H.J., De Vriese A.S. Activation of genes inducing cell-cycle arrest and of increased DNA repair in the hearts of rats with early streptozotocin-induced diabetes mellitus. Med. Sci. Monit. 2006, 12:68-74.
18. Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox (y)-sensitive transcription factors. Cell. Signal. 2002, 14:879-897.
19. Halliwell B., Gutteridge J.M., Cross C.E. Free radicals, antioxidants, and human disease: where are we now?. J. Lab. Clin. Med. 1992, 119:598-620.
20. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2008, 4:44-57.
21. Joenje H., et al. Erythrocyte superoxide dismutase deficiency in Fanconi's anaemia established by two independent methods of assay. Scand. J. Clin. Lab. Invest. 1979, 39:759-764.
22. Kennedy R., D'Andrea A. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev. 2005, 19:2925-2940.
23. Korgaonkar S., Ghosh K., Vundinti B.R. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population. Hematology 2010, 15:58-62.
24. Korgaonkar S., Ghosh K., Jijina F., Vundinti B.R. Chromosomal breakage study in children suspected with Fanconi anemia in the Indian population. J. Pediatr. Hematol. Oncol. 2010, 32:606-610.
25. Korkina L.G., Samochatova E.V., Maschan A.A., Suslova T.B., Cheremisina Z.P., Afanas' ev I.B. Release of active oxygen radicals by leukocytes of Fanconi anemia patients. J. Leukoc. Biol. 1992, 52:357-362.
26. Korthof E.T., et al. Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients. Am. J. Hematol. 2013, 88:472-476.
27. Kumari U., Ya Jun W., Huat Bay B., Lyakhovich A. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells. Oncogene 2013, 14. (10.1097).
28. Matsushita N., et al. Direct inhibition of TNF-α promoter activity by Fanconi anemia protein FANCD2. PLoS One 2011, 6. 10.1371/journal.pone.0023324.
29. Morten K.J., Ackrell B.A., Melov S. Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment. J. Biol. Chem. 2006, 281:3354-3359.
30. Muthusamy N., Barton K., Leiden J. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 1995, 377:639-642.
31. Myers K.C., et al. Impaired immune function in children with Fanconi anaemia. Br. J. Haematol. 2011, 154:234-240.
32. Novellino L., Napolitano A., Prota G. 5, 6-Dihydroxyindoles in the fenton reaction: a model study of the role of melanin precursors in oxidative stress and hyperpigmentary processes. Chem. Res. Toxicol. 1999, 12:985-992.
33. Oikawa T., Yamada T. Molecular biology of the Ets family of transcription factors. Gene 2003, 303:11-34.
34. Orkin S.H., Nathan D.G., Ginsburg D. Inherited bone marrow failure syndromes. Hematology of Infancy and Childhood 2009, 307-396. Saunders Elsevier, Philadelphia. S.H. Orkin (Ed.).
35. Pácal L., et al. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Arch. Physiol. Biochem. 2011, 117:222-230.
36. Pagano G., et al. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype. Eur. J. Haematol. 2005, 75:93-100.
37. Pagano G., Aiello Talamanca A., Castello G., Pallardó F., Zatterale A., Degan P. Oxidative stress in Fanconi anaemia: from cells and molecules toward prospects in clinical management. Biol. Chem. 2011, 393:11-21.
38. Pagano G., et al. From clinical description, to in vitro and animal studies, and backward to patients: oxidative stress and mitochondrial dysfunction in Fanconi anemia. Free Radic. Biol. Med. 2013, 58:118-125.
39. Petridou M., Barrett A.J. Physical and laboratory characteristics of heterozygote carriers of the Fanconi aplasia gene. Acta Paediatr. Scan. 1990, 79:1069-1074.
40. Schultz J.C., Shahidi N.T. Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am. J. Hematol. 1994, 45:32-38.
41. Taniguchi T., D'Andrea A.D. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006, 107:4223-4233.
42. Wu M.Y., Eldin K.W., Beaudet A.L. Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes. J. Natl. Cancer Inst. 2008, 100:1247-1259.
43. Yoshimitsu K., Kobayashi Y., Usui T. Decreased superoxide dismutase activity of erythrocytes and leukocytes in Fanconi's anemia. Acta Haematol. 1984, 72:208-210.